<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>clairol8k.txt
<DESCRIPTION>P&G PURCHASE OF CLAIROL
<TEXT>
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
Date of Report (Date of earliest event reported) May 21, 2001
THE PROCTER & GAMBLE COMPANY
-----------------------------------------------------------------------------
(Exact name of registrant as specified in its charter)
Ohio 1-434 31-0411980
-----------------------------------------------------------------------------
(State or other (Commission File Number) (IRS Employer
jurisdiction of Identification
incorporation) Number)
One Procter & Gamble Plaza, Cincinnati, Ohio 45202
-----------------------------------------------------------------------------
(Address of principal executive offices) (Zip Code)
Registrant's telephone number, including area code (513) 983-1100
--------------
ITEM 5. OTHER EVENTS
On May 21, 2001 The Procter & Gamble Company (the "Company") issued a news
release announcing that the Company will purchase the Clairol business from
Bristol-Myers Squibb Company.
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the
Registrant has duly caused this Report to be signed on its behalf by the
undersigned hereunto duly authorized.
THE PROCTER & GAMBLE COMPANY
TERRY L. OVERBEY
------------------------------------
Terry L. Overbey, Secretary
May 21, 2001
Exhibit
1. Press Release by The Procter & Gamble Company dated May 21, 2001.
</TEXT>
</DOCUMENT>